pyrazines has been researched along with Polycystic Ovary Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belosi, C; Cento, RM; Ciampelli, M; Lanzone, A; Leoni, F; Muzj, G; Romualdi, D | 1 |
| Apa, R; Ciampelli, M; Guido, M; Lanzone, A; Lattanzi, F; Leoni, F | 1 |
2 trial(s) available for pyrazines and Polycystic Ovary Syndrome
| Article | Year |
|---|---|
Metabolic and endocrine consequences of acute suppression of FFAs by acipimox in polycystic ovary syndrome.
Topics: Adult; Area Under Curve; Body Mass Index; C-Peptide; Fatty Acids, Nonesterified; Female; Glucose Tolerance Test; Growth Hormone-Releasing Hormone; Hormones; Human Growth Hormone; Humans; Hypolipidemic Agents; Insulin; Insulin Resistance; Lipids; Obesity; Polycystic Ovary Syndrome; Pyrazines | 2001 |
A pilot study of the long-term effects of acipimox in polycystic ovarian syndrome.
Topics: Adult; Blood Glucose; C-Peptide; Female; Glucose Tolerance Test; Humans; Hypolipidemic Agents; Insulin; Obesity; Pilot Projects; Polycystic Ovary Syndrome; Pyrazines; Thinness; Time Factors; Triglycerides | 2002 |